Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 124.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 124.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | | |
| Research and development | 95.5 | 66.5 | 48.8 | 32.6 | 27.9 |
| General and administrative | 29.3 | 19.6 | 12.5 | 6.5 | 5.8 |
| EBIT | -124.8 | -86.1 | -61.2 | -39.1 | -33.7 |
| EBIT margin | -99.9% | | | | |
| Pre-tax income | -126.3 | -85.5 | -59.9 | -35.4 | -34.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% |
| Net income | -126.4 | -85.6 | -59.9 | -53.8 | -49.5 |
| Net margin | -101.2% | | | | |
| |
| Diluted EPS | ($2.81) | ($3.04) | ($5.00) | ($56.10) | ($53.19) |
| Shares outstanding (diluted) | 44.9 | 28.2 | 12.0 | 1.0 | 0.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|